Global Assisted Reproductive Technology 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR072403725

Publication Date:

July 5, 2024

Pages:

110

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Assisted Reproductive Technology market size was valued at USD 48000 million in 2023 and is forecast to a readjusted size of USD 59280 million by 2030 with a CAGR of 3.1% during review period.
Assisted reproductive technology (ART) is a wide range of procedures that are used to treat infertility in men and women. Generally, ART procedures include techniques, such as IVF, ZIFT, GIFT, ICSI, and artificial insemination, which help individuals to conceive a child.
The analysts forecast the global assisted reproductive technology market to grow at a CAGR of 4.11% during the period 2017-2021.
This report includes an overview of the development of the Assisted Reproductive Technology industry chain, the market status of Fertility Clinics (General, Fertility Medication), Hospitals (General, Fertility Medication), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Assisted Reproductive Technology.
Regionally, the report analyzes the Assisted Reproductive Technology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Assisted Reproductive Technology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Assisted Reproductive Technology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Assisted Reproductive Technology industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., General, Fertility Medication).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Assisted Reproductive Technology market.
Regional Analysis: The report involves examining the Assisted Reproductive Technology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Assisted Reproductive Technology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Assisted Reproductive Technology:
Company Analysis: Report covers individual Assisted Reproductive Technology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Assisted Reproductive Technology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Fertility Clinics, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Assisted Reproductive Technology. It assesses the current state, advancements, and potential future developments in Assisted Reproductive Technology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Assisted Reproductive Technology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Assisted Reproductive Technology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
General
Fertility Medication
In Vitro Fertilization
Others
麻豆原创 segment by Application
Fertility Clinics
Hospitals
Others
麻豆原创 segment by players, this report covers
Vitrolife
Ferring Pharmaceuticals
Irvine Scientific
Cook Medical
CellCura
EMD Serono
Esco Micro
IKS International (Gonagen Medikal)
INVO Bioscience
IVFtech
Smiths Medical
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Assisted Reproductive Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Assisted Reproductive Technology, with revenue, gross margin and global market share of Assisted Reproductive Technology from 2019 to 2024.
Chapter 3, the Assisted Reproductive Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Assisted Reproductive Technology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Assisted Reproductive Technology.
Chapter 13, to describe Assisted Reproductive Technology research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Assisted Reproductive Technology
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Assisted Reproductive Technology by Type
1.3.1 Overview: Global Assisted Reproductive Technology 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Assisted Reproductive Technology Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 General
1.3.4 Fertility Medication
1.3.5 In Vitro Fertilization
1.3.6 Others
1.4 Global Assisted Reproductive Technology 麻豆原创 by Application
1.4.1 Overview: Global Assisted Reproductive Technology 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Fertility Clinics
1.4.3 Hospitals
1.4.4 Others
1.5 Global Assisted Reproductive Technology 麻豆原创 Size & Forecast
1.6 Global Assisted Reproductive Technology 麻豆原创 Size and Forecast by Region
1.6.1 Global Assisted Reproductive Technology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Assisted Reproductive Technology 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Assisted Reproductive Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Assisted Reproductive Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Assisted Reproductive Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Assisted Reproductive Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Assisted Reproductive Technology 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Vitrolife
2.1.1 Vitrolife Details
2.1.2 Vitrolife Major Business
2.1.3 Vitrolife Assisted Reproductive Technology Product and Solutions
2.1.4 Vitrolife Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Vitrolife Recent Developments and Future Plans
2.2 Ferring Pharmaceuticals
2.2.1 Ferring Pharmaceuticals Details
2.2.2 Ferring Pharmaceuticals Major Business
2.2.3 Ferring Pharmaceuticals Assisted Reproductive Technology Product and Solutions
2.2.4 Ferring Pharmaceuticals Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Ferring Pharmaceuticals Recent Developments and Future Plans
2.3 Irvine Scientific
2.3.1 Irvine Scientific Details
2.3.2 Irvine Scientific Major Business
2.3.3 Irvine Scientific Assisted Reproductive Technology Product and Solutions
2.3.4 Irvine Scientific Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Irvine Scientific Recent Developments and Future Plans
2.4 Cook Medical
2.4.1 Cook Medical Details
2.4.2 Cook Medical Major Business
2.4.3 Cook Medical Assisted Reproductive Technology Product and Solutions
2.4.4 Cook Medical Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Cook Medical Recent Developments and Future Plans
2.5 CellCura
2.5.1 CellCura Details
2.5.2 CellCura Major Business
2.5.3 CellCura Assisted Reproductive Technology Product and Solutions
2.5.4 CellCura Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 CellCura Recent Developments and Future Plans
2.6 EMD Serono
2.6.1 EMD Serono Details
2.6.2 EMD Serono Major Business
2.6.3 EMD Serono Assisted Reproductive Technology Product and Solutions
2.6.4 EMD Serono Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 EMD Serono Recent Developments and Future Plans
2.7 Esco Micro
2.7.1 Esco Micro Details
2.7.2 Esco Micro Major Business
2.7.3 Esco Micro Assisted Reproductive Technology Product and Solutions
2.7.4 Esco Micro Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Esco Micro Recent Developments and Future Plans
2.8 IKS International (Gonagen Medikal)
2.8.1 IKS International (Gonagen Medikal) Details
2.8.2 IKS International (Gonagen Medikal) Major Business
2.8.3 IKS International (Gonagen Medikal) Assisted Reproductive Technology Product and Solutions
2.8.4 IKS International (Gonagen Medikal) Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 IKS International (Gonagen Medikal) Recent Developments and Future Plans
2.9 INVO Bioscience
2.9.1 INVO Bioscience Details
2.9.2 INVO Bioscience Major Business
2.9.3 INVO Bioscience Assisted Reproductive Technology Product and Solutions
2.9.4 INVO Bioscience Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 INVO Bioscience Recent Developments and Future Plans
2.10 IVFtech
2.10.1 IVFtech Details
2.10.2 IVFtech Major Business
2.10.3 IVFtech Assisted Reproductive Technology Product and Solutions
2.10.4 IVFtech Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 IVFtech Recent Developments and Future Plans
2.11 Smiths Medical
2.11.1 Smiths Medical Details
2.11.2 Smiths Medical Major Business
2.11.3 Smiths Medical Assisted Reproductive Technology Product and Solutions
2.11.4 Smiths Medical Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Smiths Medical Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Assisted Reproductive Technology Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Assisted Reproductive Technology by Company Revenue
3.2.2 Top 3 Assisted Reproductive Technology Players 麻豆原创 Share in 2023
3.2.3 Top 6 Assisted Reproductive Technology Players 麻豆原创 Share in 2023
3.3 Assisted Reproductive Technology 麻豆原创: Overall Company Footprint Analysis
3.3.1 Assisted Reproductive Technology 麻豆原创: Region Footprint
3.3.2 Assisted Reproductive Technology 麻豆原创: Company Product Type Footprint
3.3.3 Assisted Reproductive Technology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Assisted Reproductive Technology Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Assisted Reproductive Technology 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Assisted Reproductive Technology Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Assisted Reproductive Technology 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Assisted Reproductive Technology Consumption Value by Type (2019-2030)
6.2 North America Assisted Reproductive Technology Consumption Value by Application (2019-2030)
6.3 North America Assisted Reproductive Technology 麻豆原创 Size by Country
6.3.1 North America Assisted Reproductive Technology Consumption Value by Country (2019-2030)
6.3.2 United States Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Assisted Reproductive Technology Consumption Value by Type (2019-2030)
7.2 Europe Assisted Reproductive Technology Consumption Value by Application (2019-2030)
7.3 Europe Assisted Reproductive Technology 麻豆原创 Size by Country
7.3.1 Europe Assisted Reproductive Technology Consumption Value by Country (2019-2030)
7.3.2 Germany Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Assisted Reproductive Technology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Assisted Reproductive Technology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Assisted Reproductive Technology 麻豆原创 Size by Region
8.3.1 Asia-Pacific Assisted Reproductive Technology Consumption Value by Region (2019-2030)
8.3.2 China Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Assisted Reproductive Technology Consumption Value by Type (2019-2030)
9.2 South America Assisted Reproductive Technology Consumption Value by Application (2019-2030)
9.3 South America Assisted Reproductive Technology 麻豆原创 Size by Country
9.3.1 South America Assisted Reproductive Technology Consumption Value by Country (2019-2030)
9.3.2 Brazil Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Assisted Reproductive Technology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Assisted Reproductive Technology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Assisted Reproductive Technology 麻豆原创 Size by Country
10.3.1 Middle East & Africa Assisted Reproductive Technology Consumption Value by Country (2019-2030)
10.3.2 Turkey Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Assisted Reproductive Technology 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Assisted Reproductive Technology 麻豆原创 Drivers
11.2 Assisted Reproductive Technology 麻豆原创 Restraints
11.3 Assisted Reproductive Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Assisted Reproductive Technology Industry Chain
12.2 Assisted Reproductive Technology Upstream Analysis
12.3 Assisted Reproductive Technology Midstream Analysis
12.4 Assisted Reproductive Technology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Vitrolife
Ferring Pharmaceuticals
Irvine Scientific
Cook Medical
CellCura
EMD Serono
Esco Micro
IKS International (Gonagen Medikal)
INVO Bioscience
IVFtech
Smiths Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.